Olympic Star Shannon Miller to Welcome Second Baby After Cancer Scare

Shannon Miller, US Olympic gymnast is expecting a second child, two years after she was told she cannot conceive due to a rare form of ovarian cancer.

Miller, who is the most decorated gymnast in U.S. history, is due this summer and calls her pregnancy as a miracle, as announced in her website, the Daily Mail reports.

Lung Cancer Mortality Highest in Black Persons Living in Most Segregated Counties Suggests Study
Lung cancer mortality appears to be higher in black persons and highest in blacks living in the most segregated counties in the United States, regardless of socioeconomic status.

The Olympic champion has been trying for a second child in 2010, but was in for a rude shock when doctors discovered a germ cell malignancy, a form of ovarian cancer.

After the infected ovary was removed in January 2011, Miller had nine weeks of chemotherapy, and she claimed that she is now cancer-free.

After her diagnosis in 2011, Miller said that her life, which was running smoothly with the launch of her company, Shannon Miller Lifestyle, turned upside down after she was diagnosed with cancer.

Risk of Cancer Higher With Sun Beds
A new study has cautioned users against sun beds, which they say poses double the risk of skin cancer, much more than spending the same amount of time in the Mediterranean midday summer sun.

Germ cell malignancies, which generally occur in teenagers and women under 30, are not the same as ovarian cancer.

Miller, who has a three-year-old son, Rocco with husband John Falconetti, is a two-time world all-around champion, with seven Olympic medals and nine at the world championships.

Researchers Develop Practical Technique to Produce Promising Anticancer Substance on Large Scale
A new article reports on the development of a technique through which scientists can produce large amounts of a promising new anticancer substance.

Source-ANI

DNA Marker That Predicts Breast Cancer Recurrence Discovered
University of Alberta scientists have identified a genetic marker method to profile which women were more apt to have their breast cancer return years later.